Urologix Inc (ULGX)

0.00 USD  |  OTCM  |  May 22, 16:00
More

Urologix Research and Development Expense (Quarterly): 0.298M for March 31, 2015

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.
Date Value
March 31, 2015 0.298M
December 31, 2014 0.337M
September 30, 2014 0.334M
June 30, 2014 0.344M
March 31, 2014 0.408M
December 31, 2013 0.452M
September 30, 2013 0.421M
June 30, 2013 0.513M
March 31, 2013 0.538M
December 31, 2012 0.602M
September 30, 2012 0.615M
June 30, 2012 0.577M
March 31, 2012 0.543M
December 31, 2011 0.588M
September 30, 2011 0.481M
June 30, 2011 0.583M
March 31, 2011 0.553M
December 31, 2010 0.556M
September 30, 2010 0.546M
June 30, 2010 0.513M
March 31, 2010 0.461M
December 31, 2009 0.418M
September 30, 2009 0.442M
June 30, 2009 0.516M
March 31, 2009 0.587M
Date Value
December 31, 2008 0.631M
September 30, 2008 0.622M
June 30, 2008 0.599M
March 31, 2008 0.668M
December 31, 2007 0.835M
September 30, 2007 0.678M
June 30, 2007 0.956M
March 31, 2007 0.814M
December 31, 2006 0.639M
September 30, 2006 0.616M
June 30, 2006 0.705M
March 31, 2006 0.701M
December 31, 2005 0.785M
September 30, 2005 0.796M
June 30, 2005 0.843M
March 31, 2005 0.795M
December 31, 2004 0.793M
September 30, 2004 0.642M
June 30, 2004 0.616M
March 31, 2004 0.559M
December 31, 2003 0.631M
September 30, 2003 0.584M
June 30, 2003 0.811M
March 31, 2003 0.927M
December 31, 2002 0.963M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

Perspective Therapeutics Inc 7.452M
Retractable Technologies Inc 0.1423M
Xtant Medical Holdings Inc 0.527M
Asensus Surgical Inc 8.091M
Catheter Precision Inc 0.037M